CAMP - NASDAQ

CAMP4 Therapeutics Corporation

CAMP·NASDAQ

$4.24

+1.7%

HealthcareBiotechnology

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$90.06M

EPS-2.6500

P/E Ratio-1.60

Earnings Date08/13/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

CAMP4 Therapeutics Corporation Earnings Call Transcripts

CAMP · NASDAQ

2024

Jul 10

Oct 5

Jan 9

N/A

Related Guides

Blog Categories

Continue your CAMP research with focused valuation guides.

Forecasting

Compare management guidance with modeled outcomes.

Risk Analysis

Track estimate risk, misses, and downside scenarios.

Reference

Review analyst process and transcript interpretation.

Value Investing

Anchor quarterly narrative to intrinsic value discipline.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.